Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

The ELiSA Study - Evaluation of Lixivaptan in Subjects With Autosomal Dominant Polycystic Kidney Disease

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03487913
Recruitment Status : Recruiting
First Posted : April 4, 2018
Last Update Posted : October 23, 2019
Sponsor:
Information provided by (Responsible Party):
Palladio Biosciences

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : January 2020
Estimated Study Completion Date : February 2020